Dr. Contreras on Neoadjuvant Therapies in Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Video

In Partnership With:

Carlo Contreras, MD, discusses areas of planned and ongoing research with neoadjuvant therapies in basal cell carcinoma and cutaneous squamous cell carcinoma.

Carlo Contreras, MD, surgical oncologist, The Ohio State University Comprehensive Cancer Center (OSUCCC)–James, discusses areas of planned and ongoing research with neoadjuvant therapies in basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).

Although unmet needs in BCC and CSCC lie in head-to-head, randomized clinical trials with hedgehog inhibitors, it is unlikely that that this will be explored in the future, Contreras explains. However, researchers are attempting to replicate promising results from earlier trials in new, larger trials for patients with CSCC and BCC.

Data on the use of neoadjuvant BRAF-directed therapy in melanoma demonstrate high pathologic complete response rates (pCRs), but also increased risk for short-term recurrence 2 years post-surgical resection, Contreras explains. Accordingly, evaluating long-term data from neoadjuvant trials in CSCC and BCC may reveal the risk of recurrence in this disease setting.

Overall, it is hoped that future research will result in more durable responses than what has been previously seen, he concludes.

Related Videos
Kathryn Beckermann, MD, PhD
Eleonora Dondossola, PhD
William B. Pearse, MD
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, David M. Livingston, MD, Chair, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
Rachid Baz, MD, section head, Myeloma, Department of Malignant Hematology, Moffitt Cancer Center; co-director, Pentecost Family Myeloma Research Center
Harriet Kluger, MD, Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; director, Yale SPORE in Skin Cancer; vice chair, Translational Research, Internal Medicine; chief, Division of Skin and Kidney Cancer; associate cancer center director, Education, Training and Faculty Development; deputy section chief, Medical Oncology, Yale Cancer Center
Robert DeBernardo, MD, section head, Obstetrics and Gynecology, Women’s Health Institute, Cleveland Clinic
Jacob Shreve, MD, MS, hematology/oncology fellow, Mayo Clinic
Abhishek Tripathi, MD, genitourinary medical oncologist, City of Hope
Pooja Advani, MBBS, MD, Mayo Clinic